Summary
The MULTIple Computer Automated Structure Evaluation (MULTICASE) methodology has been used to study the quantitative structure-agonist activity relationship of a series of capsaicin agonists. A number of substructures and physicochemical properties of capsaicin analogues were identified as being responsible for high agonist potency. The optimal log P value for the agonist potency as estimated from QSAR analysis is 5.12. It was also found that a cluster of inactive molecules in the database have lipophilicity values below 2.94. Molecular modeling was employed to elucidate the detailed structural features of the pharmacophore of capsaicin analogues. Systematic conformational analysishas shown that the activity of capsaicin analogues strongly depends upon their ability to reach the required conformational profile. Based upon these observations, a three-dimensional pharmacophore model for the capsaicin-receptor interactions is proposed.
Similar content being viewed by others
References
Virus, R.M. and Gebhart, G.F., Life Sci., 25 (1979) 1273.
Rozin, P., In Green, B.G., Mason, J.R. and Kare, M.R. (Eds.) Irritation, Vol. 2, Marcel Dekker, New York, NY, 1990, pp. 231–269.
Butterworth, J.F.I. and Strichartz, G.R., Anesthesiology, 72 (1990) 711.
Walpole, C.S.J., Wriggleworth, R., Bevan, S., Campbell, E.A., Dray, A., James, I.F., Masdin, K.J., Perkins, M.N. and Winter, J., J. Med. Chem., 36 (1993) 2362.
Szolcsanyi, J., In Green, B.G., Mason, J.R. and Kare, M.R. (Eds.) Irritation, Vol. 2, Marcel Dekker, New York, NY, 1990, pp. 141–168.
Yeh, J.-L., Lo, Y.-C., Wang, Y. and Chen, I.-J., Brain Res. Bull., 30 (1993) 641.
Hayes, A.G., Oxford, A., Reynolds, M., Shingler, A.H., Skingle, M., Smith, C. and Tyers, M.B., Life Sci., 34 (1984) 1241.
Cholewinski, A., Burgess, G.M. and Bevan, S., Neuroscience, 55 (1993) 1015.
Bevan, S. and Szolcsanyi, J., Trends Pharmacol. Sci., 11 (1990) 330.
Wood, J.N., Winter, J., James, I.F., Rang, H.P., Yeats, J. and Bevan, S., J. Neurosci., 8 (1988) 3208.
Fitzgerald, M., Pain, 15 (1983) 109.
James, I.F., Walpole, C.S.J., Hixon, J., Wood, J.N. and Wriggleworth, R., Mol. Pharmacol., 33 (1988) 643.
Szallasi, A. and Blumberg, P.M., Adv. Pharmacol., 24 (1991) 123.
Brand, L.M., Skare, K.L., Loomans, M.E., Reller, H.H., Schwen, R.J., Lade, D.A., Bohne, R.L., Maddin, C.S., Moorehead, D.P., Fanelli, R., Chiabrando, C., Castelli, M.G. and Tai, H.H., Agents Actions, 31 (1990) 229.
Janusz, J.M., Buckwalter, B.L., Young, P.A., Lahann, T.R., Farmer, R.W., Kasting, G.B., Loomans, M.E., Kerckaert, G.A., Maddin, C.S., Berman, E.F., Bohne, R.L., Cupps, T.L. and Milstein, J.R., J. Med. Chem., 36 (1993) 2595.
Szallasi, A. and Blumberg, P.M., Neuroscience, 30 (1989) 515.
Bevan, S., Hothi, S., Hughes, G., James, I.F., Rang, H.P., Shah, K., Walpole, C.S.J. and Yeats, J.C., Br. J. Pharmacol., 107 (1992) 544.
Szallasi, A., Goso, C., Blumberg, P.M. and Manzini, S., J. Pharmacol. Exp. Ther., 267 (1993) 728.
Szallasi, A. and Blumberg, P.M., Brain Res., 524 (1990) 106.
Winter, J., Dray, A., Wood, J.N., Yeats, J.C. and Bevan, S., Brain Res., 520 (1990) 131.
Wehmeyer, K.R., Kasting, G.B., Powell, J.H., Kuhlenbeck, D.L., Underwood, R.A. and Bowman, L.A., J. Pharm. Biomed. Anal., 8 (1990) 177.
Szallasi, A., Gen. Pharmacol., 25 (1994) 223.
Szallasi, A., Szolcsanyi, J., Szallasi, Z. and Blumberg, P.M., Naunyn-Schmiedeberg's Arch. Pharmacol., 344 (1991) 551.
Szallasi, A. and Blumberg, P.M., Life Sci., 47 (1990) 1399.
Santicioli, P., Bianco, E.D., Figini, M., Bevan, S. and Maggi, C.A., Br. J. Pharmacol., 110 (1993) 609.
Walpole, C.S.J., Bevan, S., Bovermann, G., Boelsterli, J.J., Breckenridge, R., Davies, J.W., Hughes, G.A., James, I., Oberer, L., James, I.F., Winter, J. and Wriggleworth, R., J. Med. Chem., 37 (1994) 1942.
Szolcsanyi, J. and Jancso-Gabor, A., Arzneim.-Forsch. Drug Res., 25 (1975) 1877.
Szolcsanyi, J. and Jancso-Gabor, A., Arzneim.-Forsch. Drug Res., 26 (1976) 33.
Walpole, C.S.J., Wriggleworth, R., Bevan, S., Campbell, E.A., Dray, A., James, I.F., Masdin, K.J., Perkins, M.N. and Winter, J., J. Med. Chem., 36 (1993) 2373.
Walpole, C.S.J., Wriggleworth, R., Bevan, S., Campbell, E.A., Dray, A., James, I.F., Masdin, K.J., Perkins, M.N. and Winter, J., J. Med. Chem., 36 (1993) 2381.
Walpole, C.S.J. and Wriggleworth, R., In Wood, J.N. (Ed.) Capsaicin in the Study of Pain, Harcourt Brace, San Diego, CA, 1993, pp. 63–81.
Klopman, G., J. Am. Chem. Soc., 106 (1984) 7315.
Klopman, G., Quant. Struct.-Act. Relatsh., 11 (1992) 176.
Klopman, G., Li, J.-Y., Wang, S. and Dimayuga, M., J. Chem. Inf. Comput. Sci., 34 (1994) 752.
Klopman, G., Wang, S. and Balthasar, D.M., J. Comput. Chem., 32 (1992) 474.
Van, Catledge, F.A., J. Org. Chem., 45 (1980) 4801.
Insight II, Version 2.2.0, Biosym Technologies Inc., San Diego, CA, 1992.
Dauber-Osguthorpe, P., Roberts, V.A., Osguthorpe, D.J., Wolff, J., Genest, M. and Hagler, A.T., Protein Struct. Funct. Genet., 4 (1988) 31.
Strichartz, G.R., Sanchez, V., Arthur, G.R., Chafetz, R. and Martin, D., Anesth. Analg., 71 (1990) 158.
Bradley, D.J. and Richards, C.D., Br. J. Pharmacol., 81 (1984) 161.
Hansch, C., Bjorkroth, J.P. and Leo, A., J. Pharm. Sci., 76 (1987) 663.
Szallasi, A. and Blumberg, P.M., Life Sci., 48 (1991) 1863.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klopman, G., Li, JY. Quantitative structure-agonist activity relationship of capsaicin analogues. J Computer-Aided Mol Des 9, 283–294 (1995). https://doi.org/10.1007/BF00124458
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00124458